BRIANA OLIVEROS: Open Payments
NPI 1760071914 · OCALA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$907 in 35 payments from 15 companies in 2025. Trend: 2023 $1,799 · 2024 $956 · 2025 $907
Food & beverage: $907
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $214 |
| Boston Scientific Corporation | 1 | $150 |
| ANI Pharmaceuticals, Inc. | 1 | $122 |
| AstraZeneca Pharmaceuticals LP | 5 | $110 |
| Vantive US Healthcare LLC | 2 | $49 |
| Ardelyx, Inc. | 2 | $44 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
| Mallinckrodt Hospital Products Inc. | 2 | $40 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Calliditas Therapeutics US Inc. | 1 | $22 |
Products named: Fabhalta, WATCHMAN FLX, PURIFIED CORTROPHIN GEL, FARXIGA, Vanrafia, Renal - PD, IBSRELA, ULTOMIRIS.
Industry payments across FL — which companies pay providers there.
